Is the platelet-to-lymphocyte ratio a new prognostic marker in multiple myeloma?

Published on Oct 1, 2018in Journal of Laboratory Physicians
· DOI :10.4103/JLP.JLP_36_18
Serife Medeni Solmaz2
Estimated H-index: 2
Ozcan Uzun + 8 AuthorsInci Alacacioglu8
Estimated H-index: 8
(Dokuz Eylül University)
BACKGROUND: Recent reports showed neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR), as a predictor of progression-free survival (PFS) and overall survival (OS) in various malignancies. MATERIALS AND METHODS: We retrospectively examined the PLR, NLR, and MLR in a cohort of 186 newly diagnosed multiple myeloma (MM) patients. This study investigated the prognostic relevance of NLR, PLR, and MLR in MM patients. NLR, PLR, and MLR were calculated from whole blood counts before therapy. The Kaplan–Meier curves and multivariate Cox models were used for the evaluation of survival. RESULTS: Applying cutoff of 1.9 (NLR), 120.00 (PLR), and 0.27 (MLR), decreased PLR showed a negative impact on the outcome. Decreased PLR is an independent predictor for PFS and OS. There were no significant differences in median survival between the high and low NLR (P = 0.80) and MLR (P = 0.87) groups. CONCLUSIONS: In this study, thrombocytopenia and low PLR are associated with poor survival in MM patients does this P value apply to thrombocytopenia or low PLR and may serve as the cost-effective prognostic biomarker.
  • References (0)
  • Citations (0)
📖 Papers frequently viewed together
7 Authors (Ni J, ..., Xia Rx)
4 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
Cited By0
#1Aneta Szudy-Szczyrek (Medical University of Lublin)H-Index: 2
#2Radosław Mlak (Medical University of Lublin)H-Index: 7
Last. Agata A. Filip (Medical University of Lublin)H-Index: 6
view all 12 authors...
Neutrophils to lymphocytes ratio (NLR) and platelets to lymphocytes ratio (PLR) are considered as laboratory markers of inflammation. They can be potentially useful in predicting the course of multiple neoplasms including selected hematological cancers. The aim of the study was to assess the value of NLR and PLR in predicting the effects of therapy and prognosis in multiple myeloma patients treated with thalidomide-based regimen. The study group consisted of 100 patients treated with the first l...